🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us at the UAPA meeting in Denver, March 27-30! Stop by our booth to learn how #DecipherProstate Genomic Classifier by Veracyte, Inc. brings clarity & confidence to treatment planning. #UrologicCancer #PrecisionMedicine

Join us tomorrow, March 27-29 at the 30th Annual Paul C. Peters Urology Symposium! Visit our #DecipherTeam by Veracyte, Inc. to learn about how the Decipher Prostate test offers physicians actionable insights to help in #ProstateCancer decision-making.

Heading to Baltimore, MD, for the University of Maryland Rad Onc Symposium on March 28? So are we! Stop by the #DecipherTeam booth by Veracyte, Inc. to learn how we're using genomics to transform care for #ProstateCancer patients. #UrologicCancer #PrecisionMedicine

Findings from TOMBOLA Trial presented at #EAU25: New data demonstrate accuracy of our whole-genome sequencing-based #MRD testing platform for muscle-invasive bladder cancer. investor.veracyte.com/news-releases/… #UrologicCancer #PrecisionMedicine Cautionary note - veracyte.com/cautionary-not…

We’re attending the University of Texas' 3rd Annual Christopher G. Wood Advances in Urologic Oncology Symposium from April 4–6! Visit our booth to learn how #DecipherProstate by Veracyte, Inc. provides clarity and confidence in treatment planning. #UrologicOncology #ProstateCancer

Save the date! The #DecipherTeam by Veracyte, Inc. is headed to Overland Park, KS, for the Kansas Urological Society & Missouri Urological Association’s 15th Annual Collaborative Forum on April 5! Visit our booth to learn how we’re changing #ProstateCancer patient care.

Join us tomorrow, April 5 at the Iowa Urological Society! Visit the #DecipherProstate by Veracyte, Inc. team to learn about how the Decipher Prostate test offers physicians actionable insights to help in #ProstateCancer decision-making. #UrologicOncology #PrecisionMedicine

We're excited to attend the San Diego Urological Society Meeting in San Diego, CA, on April 9! Visit our booth to connect with our team and discover how the #DecipherProstate Genomic Classifier by Veracyte, Inc., Inc. provides clarity and confidence in treatment planning.

Join us April 11–12 at the Rocky Mountain Urological Society! Visit the #DecipherTeam from Veracyte, Inc., Inc. to learn how the Decipher Prostate test provides physicians with actionable insights to help patients make informed decisions. #ProstateCancer #UrologicOncology

Genomic classifier #Decipher® guides treatment intensification in post-prostatectomy patients. Phuoc T. Tran University of Maryland School of Medicine joins Angela Jia RadOncUH to discuss findings from the RTOG 0534 #SPPORT trial examining the Decipher® genomic classifier scores as predictors of treatment

Join us April 26-28 in Las Vegas, NV, for the American Urological Association (AUA) Annual Meeting. Visit the #DecipherTeam by Veracyte, Inc. at booth #1015 to learn how we support patients living with #ProstateCancer. #AUA25 #UrologicOncology #PrecisionMedicine

🔬 This week at #AUA2025: 18 abstracts on our Decipher Prostate & Decipher Bladder tests. Data includes clinical trial results & cancer biology insights derived through use of the Decipher GRID research tool. Explore - investor.veracyte.com/news-releases/… Note - veracyte.com/cautionary-not…

📣 The #DecipherProstate Metastatic Genomic Classifier is now available to select clinical sites through an early access program, with broader availability in June 2025. #OncologyInnovation #PrecisionMedicine Learn more: investor.veracyte.com/news-releases/… Note: veracyte.com/cautionary-not…

Biomarkers for gemcitabine docetaxel in non-muscle invasive #BladderCancer. Vignesh Packiam, MD Rutgers Cancer Institute joins Joep J. de Jong Erasmus MC to discuss promising results for non-muscle invasive bladder cancer, with potential biomarkers on the horizon for precision medicine. #WatchNow

Treatment intensification strategies for high-risk #ProstateCancer patients. Aaron Berger, MD Associated Urological Specialists joins Eric Kim, MD University of Nevada, Reno to discuss a shift away from surgery & adjuvant RT, favoring early salvage guided by Decipher®. His group uses Orgovyx for ADT—fast-acting,

Swing by! #DecipherProstate by Veracyte, Inc. is at the Massachusetts Association of Practicing Urologists Spring meeting (MAPU), in Walhtam, MA. Visit us tomorrow May 13 to learn how we're transforming #ProstateCancer care! #UrologicCancer #PrecisionMedicine

🚨Can the transcriptome reveal therapeutic vulnerabilities in localized #prostatecancer?🚨 👉Check out our analysis of >140k tumor samples in European Urology Oncology 🔗shorturl.at/k0J3H

Join us at the Oregon Urological Society, in Sunriver, OR, from May 16-18. Stop by the #Decipher by Veracyte, Inc. booth to discuss how we are informing #ProstateCancer patient care. #UrologicCancer #PrecisionMedicine

We will be attending the Regreso A Casa meeting, in Condado, PR, on May 17! If you're here, stop by our booth and speak with our team to learn how #DecipherProstate Genomic Classifier by Veracyte, Inc. can help provide clarity & confidence for treatment planning. #UrologicCancer

Advancing Urologic Cancer Care at #ASCO25: We're excited to announce multiple Decipher-focused abstracts will be presented this week in Chicago, delivering high-value insights for oncology professionals. 📊 Learn more about the new data on Decipher Prostate, Bladder, and GRID -